ID27153A - Senyawa inhibitor spla2 untuk mengobati penyakit - Google Patents

Senyawa inhibitor spla2 untuk mengobati penyakit

Info

Publication number
ID27153A
ID27153A IDW20002214A ID20002214A ID27153A ID 27153 A ID27153 A ID 27153A ID W20002214 A IDW20002214 A ID W20002214A ID 20002214 A ID20002214 A ID 20002214A ID 27153 A ID27153 A ID 27153A
Authority
ID
Indonesia
Prior art keywords
inhibitor compounds
treat disease
spla2 inhibitor
spla2
treat
Prior art date
Application number
IDW20002214A
Other languages
English (en)
Inventor
William Louis Macias
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID27153A publication Critical patent/ID27153A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20002214A 1998-05-01 1999-04-20 Senyawa inhibitor spla2 untuk mengobati penyakit ID27153A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8387498P 1998-05-01 1998-05-01

Publications (1)

Publication Number Publication Date
ID27153A true ID27153A (id) 2001-03-08

Family

ID=22181224

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002214A ID27153A (id) 1998-05-01 1999-04-20 Senyawa inhibitor spla2 untuk mengobati penyakit

Country Status (20)

Country Link
US (1) US6340699B1 (id)
EP (1) EP1084108A4 (id)
JP (1) JP2002513783A (id)
KR (1) KR20010043190A (id)
CN (1) CN1299348A (id)
AU (1) AU3656299A (id)
BR (1) BR9910095A (id)
CA (1) CA2330856A1 (id)
CZ (1) CZ20004052A3 (id)
EA (1) EA200001140A1 (id)
HR (1) HRP20000739A2 (id)
HU (1) HUP0102243A2 (id)
ID (1) ID27153A (id)
IL (1) IL139019A0 (id)
NO (1) NO20005479L (id)
PL (1) PL343708A1 (id)
SK (1) SK16342000A3 (id)
TR (1) TR200003194T2 (id)
WO (1) WO1999057100A1 (id)
ZA (1) ZA200005563B (id)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962300A1 (de) * 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
AU2001236440A1 (en) * 2000-01-25 2001-08-07 Eli Lilly And Company Method for the treatment of inflammation with spla2 inhibitors
AU2001267823A1 (en) * 2000-06-29 2002-01-08 Shionogi And Co., Ltd. Compounds exhibiting x-type spla2 inhibiting effect
CZ2003176A3 (cs) * 2000-07-24 2003-06-18 Dov Global Technologies Inc. Prostředky z termoplastického superabsorpčního polymerního blendu a jejich příprava
MX2008005664A (es) * 2005-11-03 2008-12-15 Ilypsa Inc Compuestos de indol que tienen sustituyentes c4-acidos y uso de los mismos como inhibidores de fosfolipasa a2.
AU2009232836A1 (en) * 2008-04-01 2009-10-08 Astellas Pharma Inc. Indolinone compound
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
US9290752B2 (en) 2013-03-13 2016-03-22 Sunny Delight Beverages Co. Process for enhancing the amylase inhibitory efficacy from phaseolus vulgaris extracts

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356919A (en) 1991-05-30 1994-10-18 G. D. Searle & Co. Leukotriene B4 synthesis inhibitors
DE4218096A1 (de) 1992-06-02 1993-12-09 Boehringer Mannheim Gmbh Spiro-oxetane, Verfahren zu ihrer Herstellung und Arzneimittel
DE4323409A1 (de) 1993-07-13 1995-01-19 Boehringer Mannheim Gmbh Verwendung von Cumarinen und Carbostyrilen als PLA¶2¶-Inhibitoren, neue Cumarine und Carbostyrile, Verfahren zu ihrer Herstellung und Arzneimittel
MY112897A (en) 1994-04-01 2001-10-31 Lilly Co Eli Ih-indole-3-glyoxylamide spla2 inhibitors
WO1995033462A1 (en) * 1994-06-02 1995-12-14 Smithkline Beecham Corporation Anti-inflammatory compounds
NZ298145A (en) 1994-12-29 1998-08-26 Yamanouchi Pharma Co Ltd Monoclonal antibodies having inhibitory effect on type ii phospholipase a2, proteins forming part thereof, cells producing them, dna encoding them, recombinant vector comprising the dna and medicament
CZ136899A3 (cs) 1996-10-30 1999-09-15 Eli Lilly And Company Substituované tricyklické sloučeniny
NZ506329A (en) * 1998-02-25 2004-01-30 Inst Genetics Llc Inhibitors of phospholipase enzymes

Also Published As

Publication number Publication date
ZA200005563B (en) 2002-01-10
CA2330856A1 (en) 1999-11-11
CZ20004052A3 (cs) 2002-05-15
EA200001140A1 (ru) 2001-04-23
BR9910095A (pt) 2000-12-26
EP1084108A4 (en) 2005-01-12
US6340699B1 (en) 2002-01-22
PL343708A1 (en) 2001-08-27
KR20010043190A (ko) 2001-05-25
CN1299348A (zh) 2001-06-13
SK16342000A3 (sk) 2002-04-04
WO1999057100A1 (en) 1999-11-11
HUP0102243A2 (hu) 2001-10-28
EP1084108A1 (en) 2001-03-21
JP2002513783A (ja) 2002-05-14
NO20005479L (no) 2000-12-20
NO20005479D0 (no) 2000-10-31
TR200003194T2 (tr) 2001-03-21
IL139019A0 (en) 2001-11-25
AU3656299A (en) 1999-11-23
HRP20000739A2 (en) 2001-10-31

Similar Documents

Publication Publication Date Title
DE69929020D1 (de) Rohrschuh
CU23063A3 (es) Imidazotriazinonas 2-fenil sustituidas como inhibidores de fosfodiesterasas
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
NO20010760L (no) Griperenhet for brönntraktorer
NO20012995D0 (no) Forbindelse nyttige for behandling av inflammatoriske sykdommer
PT1181017E (pt) Inibidores de metaloproteases
LTC1124961I2 (lt) Trombopoetino junginiai
ATE229954T1 (de) Betacarbolinverbindungen
ID28266A (id) Senyawa-senyawa amidin
NO20016319L (no) VLA-4 inhibitor-forbindelser
NO20011745L (no) Forbindelser
ID27346A (id) Peralatan pengenal suara
NO20005006L (no) Kalsilytiske forbindelser
ID29139A (id) Metode granulasi basah untuk menghasilkan granul-granul
NO20006662L (no) Fluorfenylresin-forbindelser
ID27153A (id) Senyawa inhibitor spla2 untuk mengobati penyakit
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
ID29966A (id) Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
FI973929A (fi) WOF inhibiittori
NO20010060D0 (no) Vannrensing
DE69908679D1 (de) Verfahren zum Weitern
ID27298A (id) Peningkatan hidrolik komponen-komponen
PT1175417E (pt) Compostos substituidos de benzolactamas
DE69828361D1 (de) Apoptose-inhibitor